As global approvals of new anti-obesity medicines accelerate, drugmakers have a public service announcement for the world: Obesity is a disease. Eli Lilly launched a website asserting that obesity is not merely a risk factor for medical complications but a chronic and complex medical entity in its own right
The Science Behind Semaglutide: Why Weekly Dosing is Standard Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, represents a significant advancement in both type 2 diabetes management and chronic weight management
This includes: Lean Proteins: Chicken, turkey, fish, tofu, and legumes are crucial for maintaining muscle mass during weight loss and promoting satiety
Making matters worse, medical researchers note that some strains of candida are evolving to become drug-resistant, making treating the condition more difficult (PubMed: Drug Resistance in Candida)
Clearer thinking often emerges when anxiety decreases